1. Home
  2. CLWT vs INDP Comparison

CLWT vs INDP Comparison

Compare CLWT & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLWT
  • INDP
  • Stock Information
  • Founded
  • CLWT 1971
  • INDP 2000
  • Country
  • CLWT Hong Kong
  • INDP United States
  • Employees
  • CLWT N/A
  • INDP N/A
  • Industry
  • CLWT Professional and commerical equipment
  • INDP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLWT Consumer Discretionary
  • INDP Health Care
  • Exchange
  • CLWT Nasdaq
  • INDP Nasdaq
  • Market Cap
  • CLWT 8.9M
  • INDP 8.8M
  • IPO Year
  • CLWT 1997
  • INDP N/A
  • Fundamental
  • Price
  • CLWT $1.19
  • INDP $0.52
  • Analyst Decision
  • CLWT
  • INDP Strong Buy
  • Analyst Count
  • CLWT 0
  • INDP 2
  • Target Price
  • CLWT N/A
  • INDP $8.50
  • AVG Volume (30 Days)
  • CLWT 10.5K
  • INDP 1.2M
  • Earning Date
  • CLWT 04-29-2025
  • INDP 03-13-2025
  • Dividend Yield
  • CLWT 6.72%
  • INDP N/A
  • EPS Growth
  • CLWT 630.02
  • INDP N/A
  • EPS
  • CLWT 0.28
  • INDP N/A
  • Revenue
  • CLWT $17,242,000.00
  • INDP N/A
  • Revenue This Year
  • CLWT N/A
  • INDP N/A
  • Revenue Next Year
  • CLWT N/A
  • INDP N/A
  • P/E Ratio
  • CLWT $3.96
  • INDP N/A
  • Revenue Growth
  • CLWT 6.59
  • INDP N/A
  • 52 Week Low
  • CLWT $1.08
  • INDP $0.51
  • 52 Week High
  • CLWT $1.94
  • INDP $3.10
  • Technical
  • Relative Strength Index (RSI)
  • CLWT 33.78
  • INDP 25.33
  • Support Level
  • CLWT $1.18
  • INDP $0.58
  • Resistance Level
  • CLWT $1.25
  • INDP $0.78
  • Average True Range (ATR)
  • CLWT 0.07
  • INDP 0.14
  • MACD
  • CLWT -0.02
  • INDP -0.02
  • Stochastic Oscillator
  • CLWT 0.00
  • INDP 0.41

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: